Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
+480K
-
Total reported value, excl. options
-
$568M
-
Value change
-
+$17.1M
-
Put/Call ratio
-
0.66
-
Number of buys
-
47
-
Number of sells
-
-36
-
Price
-
$29.70
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2016
100 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q3 2016.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
of 62.5M outstanding shares and own 30.63% of the company stock.
Largest 10 shareholders include FMR LLC (3.93M shares), BVF INC/IL (2.77M shares), WELLINGTON MANAGEMENT GROUP LLP (1.12M shares), BlackRock Fund Advisors (912K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (911K shares), VICTORY CAPITAL MANAGEMENT INC (815K shares), Opaleye Management Inc. (785K shares), VANGUARD GROUP INC (712K shares), Boxer Capital, LLC (705K shares), and FIL Ltd (629K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.